INmune Bio Inc. (INMB) CEO R.J. Tesi on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha]
INmune Bio Inc. - Common stock (INMB)
Company Research
Source: Seeking Alpha
INmune Bio Inc. (NASDAQ: INMB Company Participants R.J. Tesi - CEO David Moss - CFO Conference Call Participants Jonathan Aschoff - ROTH Capital Partners Swayampakula Ramakanth - H. C. Wainwright Carl Byrnes - Northland Securities Daniel Carlson - Tailwinds Research David Bautz - Zacks Investment Research Paul Morris - Alliance Global Partners Michael Erwin - Universe Securities Operator Greetings and welcome to the INmune Bio’s Fourth Quarter and Full Year 2019 Earnings Call. At this time, all lines have been placed on a listen-only mode and the floor will be open for questions and comments following the presentation. [Operator Instructions] As a reminder, this conference is recorded. A transcript will follow within 24 hours of this conference call. At the time, it is my pleasure to introduce your host, [Lyndon Britto]. Lyndon, the floor is yours. Unidentified Company Representative Thank you, Christine. Good morning. Good afternoon everyone. We thank all of you for joining us for th
Show less
Read more
Impact Snapshot
Event Time:
INMB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INMB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INMB alerts
High impacting INmune Bio Inc. - Common stock news events
Weekly update
A roundup of the hottest topics
INMB
News
- INmune Bio Independent Director Acquires 80% More Stock [Yahoo! Finance]Yahoo! Finance
- INmune Bio Inc. Announces $9.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules [Yahoo! Finance]Yahoo! Finance
- INmune Bio Inc. Announces $9.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesGlobeNewswire
- INmune Bio Inc. Announces 24-Month Stability Validation of XPro™ for Phase III Readiness and Commercial Supply Chain Modeling & Development of Novel Immunogenicity Assay [Yahoo! Finance]Yahoo! Finance
- INmune Bio Inc. Announces 24-Month Stability Validation of XPro™ for Phase III Readiness and Commercial Supply Chain Modeling & Development of Novel Immunogenicity AssayGlobeNewswire
INMB
Sec Filings
- 4/26/24 - Form 8-K
- 4/26/24 - Form 424B5
- 4/25/24 - Form 8-K
- INMB's page on the SEC website